Microbot Medical is transitioning from R&D to commercialization with its LIBERTY single-use robotic system for endovascular interventions. I assign MBOT a neutral rating with a 1-year price target of ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Henry Chandonnet Every time Henry publishes a story, you’ll get an alert straight to your inbox ...

AI coding tools act like power tools for programmers. Programming jobs will change, but not disappear entirely. New tester and AI-wrangler roles will grow alongside coders. Something terrifying is ...

Fintel reports that on November 28, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 434.50% Upside As of ...

A major contributor from the early days of emulation finally gets his flowers. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

Melissa Sarnowski has been a game writer for over two years. While she's willing to dig into any game for an article, she heavily focuses on The Legend of Zelda, Resident Evil, Final Fantasy, and The ...

Perl was once everywhere. Or at least it felt that way. Around the turn of the millennium, it seemed that almost every website was built on the back of this scripting language. It processed massive ...